Synapse

← Clinical & Translational Immunology

Papers in Clinical & Translational Immunology

Page 5 · newest first

  1. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patientsClinical & Translational Immunology · 2022
  2. Homologous peptides derived from influenza A, B and C viruses induce variable CD8⁺ T cell responses with cross‐reactive potentialClinical & Translational Immunology · 2022
  3. Glycolipid‐peptide conjugate vaccines elicit CD8⁺ T‐cell responses and prevent breast cancer metastasisClinical & Translational Immunology · 2022
  4. Identification of polo‐like kinase 1 as a therapeutic target in murine lupusClinical & Translational Immunology · 2022
  5. Inflammasome activation: from molecular mechanisms to autoinflammationClinical & Translational Immunology · 2022
  6. Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgeryClinical & Translational Immunology · 2022
  7. TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expressionClinical & Translational Immunology · 2022
  8. Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeuticsClinical & Translational Immunology · 2022
  9. Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesisClinical & Translational Immunology · 2022
  10. Severe COVID‐19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individualsClinical & Translational Immunology · 2022
  11. Effect of washed versus unwashed red blood cells on transfusion‐related immune responses in preterm newbornsClinical & Translational Immunology · 2022
  12. Heterologous SARS‐CoV ‐2 IgA neutralising antibody responses in convalescent plasmaClinical & Translational Immunology · 2022
  13. Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapyClinical & Translational Immunology · 2022
  14. Optimising the IgG‐degrading enzyme treatment regimen for enhanced adeno‐associated virus transduction in the presence of neutralising antibodiesClinical & Translational Immunology · 2022
  15. Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccinationClinical & Translational Immunology · 2022
  16. High‐resolution analysis of individual spike peptide‐specific CD4⁺ T‐cell responses in vaccine recipients and COVID‐19 patientsClinical & Translational Immunology · 2022
  17. Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasisClinical & Translational Immunology · 2022
  18. Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trialClinical & Translational Immunology · 2022
  19. Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategiesClinical & Translational Immunology · 2022
  20. Increased mast cell activation in eosinophilic chronic obstructive pulmonary diseaseClinical & Translational Immunology · 2022
  21. Diversification and shared features of tumor‐binding antibody repertoires in tumor, sentinel lymph node and blood of three patients with breast cancerClinical & Translational Immunology · 2022
  22. Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinomaClinical & Translational Immunology · 2022
  23. Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidateClinical & Translational Immunology · 2022
  24. Anti‐thymocyte globulin‐mediated immunosenescent alterations of T cells in kidney transplant patientsClinical & Translational Immunology · 2022
  25. Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropeniaClinical & Translational Immunology · 2022
  26. A peptoid interleukin‐15 receptor antagonist suppresses inflammation and arthritis in miceClinical & Translational Immunology · 2022
  27. YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF‐κB signalling pathways via inhibiting EPHB3 and TNFAIP3Clinical & Translational Immunology · 2022
  28. Interleukin‐17A and interleukin‐22 production by conventional and non‐conventional lymphocytes in three different end‐stage lung diseasesClinical & Translational Immunology · 2022
  29. Targeting SARS‐CoV ‐2 infection through CAR‐T ‐like bispecific T cell engagers incorporating ACE2Clinical & Translational Immunology · 2022
  30. The frequency of Treg subsets distinguishes disease activity in ANCA vasculitisClinical & Translational Immunology · 2022
  31. A new flow cytometry assay identifies recipient IgG subtype antibodies binding donor cells: increasing donor availability for highly sensitised patientsClinical & Translational Immunology · 2022
  32. Genes involved in platelet aggregation and activation are downregulated during acute anaphylaxis in humansClinical & Translational Immunology · 2022
  33. Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over timeClinical & Translational Immunology · 2022
  34. LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenzaClinical & Translational Immunology · 2022
  35. Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assaysClinical & Translational Immunology · 2022
  36. Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccineClinical & Translational Immunology · 2022
  37. DROSHA but not DICER is required for human haematopoietic stem cell functionClinical & Translational Immunology · 2022
  38. Increased amphiregulin expression by CD4 + T cells from individuals with asymptomatic Leishmania donovani infectionClinical & Translational Immunology · 2022
  39. Immunosenescence: an unexplored role in glomerulonephritisClinical & Translational Immunology · 2022
  40. Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic jointClinical & Translational Immunology · 2022
  41. Parallel detection of SARS‐CoV ‐2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID ‐19 donorsClinical & Translational Immunology · 2022
  42. The immunopathogenesis of SARS ‐CoV‐2 infection in children: diagnostics, treatment and preventionClinical & Translational Immunology · 2022
  43. Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal studyClinical & Translational Immunology · 2022
  44. Intimal macrophages develop from circulating monocytes during vasculitisClinical & Translational Immunology · 2022
  45. Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptideClinical & Translational Immunology · 2022
  46. Neutrophils contribute to elevated BAFF levels to modulate adaptive immunity in patients with primary immune thrombocytopenia by CD62P and PSGL1 interactionClinical & Translational Immunology · 2022
  47. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19Clinical & Translational Immunology · 2022
  48. Early‐like differentiation status of systemic PD ‐1+ CD8 + T cells predicts PD ‐1 blockade outcome in non‐small cell lung cancerClinical & Translational Immunology · 2022
  49. SARS‐CoV ‐2 triggers complement activation through interactions with heparan sulfateClinical & Translational Immunology · 2022
  50. G‐CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironmentClinical & Translational Immunology · 2022